144 related articles for article (PubMed ID: 37068275)
1. Long-Term Health Consequences After Ovarian Removal at Benign Hysterectomy : A Nationwide Cohort Study.
Gottschau M; Rosthøj S; Settnes A; Aalborg GL; Viuff JH; Munk C; Jensen A; Kjær SK; Mellemkjær L
Ann Intern Med; 2023 May; 176(5):596-604. PubMed ID: 37068275
[TBL] [Abstract][Full Text] [Related]
2. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
3. Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study.
Gottschau M; Kjær SK; Viuff JH; Jensen A; Munk C; Settnes A; Mellemkjær L
Breast Cancer Res Treat; 2023 Feb; 197(3):583-591. PubMed ID: 36482232
[TBL] [Abstract][Full Text] [Related]
4. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL;
Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528
[TBL] [Abstract][Full Text] [Related]
5. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
Wilson LF; Pandeya N; Byles J; Mishra GD
Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
[TBL] [Abstract][Full Text] [Related]
6. Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis.
Hermens M; van Altena AM; Bulten J; van Vliet HAAM; Siebers AG; Bekkers RLM
Fertil Steril; 2022 May; 117(5):938-945. PubMed ID: 35300832
[TBL] [Abstract][Full Text] [Related]
7. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women.
Appiah D; Winters SJ; Hornung CA
Diabetes Care; 2014; 37(3):725-33. PubMed ID: 24194507
[TBL] [Abstract][Full Text] [Related]
8. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study.
Kim M; Kim BH; Lee H; Nam H; Park S; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Kim IJ
Eur J Endocrinol; 2021 Jan; 184(1):143-151. PubMed ID: 33112277
[TBL] [Abstract][Full Text] [Related]
10. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
11. Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions.
Töz E; Özcan A; Balsak D; Avc ME; Eraslan AG; Balc DD
Menopause; 2016 Feb; 23(2):138-42. PubMed ID: 26382316
[TBL] [Abstract][Full Text] [Related]
12. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
Matthews CA
Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
[TBL] [Abstract][Full Text] [Related]
13. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV
Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323
[TBL] [Abstract][Full Text] [Related]
14. Concomitant Bilateral Salpingo-Oophorectomy at Hysterectomy: Differences by Race and Menopausal Status in the Veterans Affairs Health Care System, 2007-2014.
Bossick AS; Katon JG; Gray KE; Ma EW; Callegari LS
J Womens Health (Larchmt); 2020 Dec; 29(12):1513-1519. PubMed ID: 33095114
[No Abstract] [Full Text] [Related]
15. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073
[TBL] [Abstract][Full Text] [Related]
16. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease.
Matthews CA
J Womens Health (Larchmt); 2013 Sep; 22(9):755-9. PubMed ID: 23865788
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
Assaf W; Andraous M; Lavie O; Segev Y
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
[TBL] [Abstract][Full Text] [Related]
18. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.
Jacoby VL; Vittinghoff E; Nakagawa S; Jackson R; Richter HE; Chan J; Kuppermann M
Obstet Gynecol; 2009 Jun; 113(6):1259-1267. PubMed ID: 19461420
[TBL] [Abstract][Full Text] [Related]
20. Long-term cancer risk after hysterectomy on benign indications: Population-based cohort study.
Altman D; Yin L; Falconer H
Int J Cancer; 2016 Jun; 138(11):2631-8. PubMed ID: 26800386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
